UPDATE : Thursday, April 18, 2019
상단여백
Korean patients lack knowledge about risk of resistance development by BTX
More than half of the people who have undergone botulinum toxin (BTX) treat...
by Lee Han-soo  |  2019-03-15 15:39
라인
Dong-A ST slapped with ₩13.8 billion penalty for bribing doctors
The Ministry of Health and Welfare has ordered the suspension of reimbursem...
by Kwak Sung-sun  |  2019-03-15 15:38
라인
Theragen’s Lou Gehrig's disease treatment wins government support
Theragen ETEX said Friday that the Korea Drug Development Fund (KDDF) would...
by Lee Han-soo  |  2019-03-15 13:21
라인
SK Chemicals executive arrested for destroying evidence in humidifier sterilizers case
A high-ranking official at SK Chemicals has been arrested for trying to cov...
by Jeong Sae-im  |  2019-03-15 11:41
라인
Pharmbio Korea to develop antifungal drug with BioSynectics’ nanotechnology
Pharmbio Korea said Wednesday that it has signed a licensing-in deal with B...
by Lee Han-soo  |  2019-03-13 17:48
라인
Daewoong to enter P3 trial for Nabota in China
Daewoong Pharmaceutical said Wednesday that the China Food and Drug Adminis...
by Lee Han-soo  |  2019-03-13 15:43
라인
Regulator OKs Yuyu’s P2 clinical trial into dry eye treatment
Yuyu Pharmaceutical said Wednesday that the Ministry of Food and Drug Safet...
by Lee Han-soo  |  2019-03-13 12:43
라인
Tecentriq becomes 1st immunotherapy OKed for specific breast cancer
Roche said its PD-L1 (programmed death-ligand 1) inhibitor Tecentriq (ingre...
by Kim Yun-mi  |  2019-03-13 12:43
라인
GemVax & KAEL completes patient enrollment for P2 clinical trial into GV1001
GemVax & KAEL said Wednesday that it has completed patient registration for...
by Lee Han-soo  |  2019-03-13 10:49
라인
Dong-A ST’s erectile dysfunction treatment improves postmicturition dribbling
Dong-A ST said Monday that it has confirmed that Zydena (ingredient: Udenaf...
by Lee Han-soo  |  2019-03-12 18:02
라인
ImmuneOncia ends P1 clinical trials for solid cancer treatment
ImmuneOncia Therapeutics, a subsidiary of Yuhan Corp., said Tuesday that it...
by Lee Han-soo  |  2019-03-12 17:46
라인
Drugmakers to name new CEOs, enhance ownership
The pharmaceutical industry is expected to witness significant changes in m...
by Jeong Sae-im  |  2019-03-12 16:17
라인
Regulator OKs Humedix’s osteoarthritis treatment
Humedix said Monday that it has received sales approval for Humia, an osteo...
by Lee Han-soo  |  2019-03-12 13:55
라인
HanAll starts P3 clinical trials for dry eye treatment in US
HanAll Biopharma, a subsidiary of Daewoong Pharmaceuticals, said Tuesday th...
by Lee Han-soo  |  2019-03-12 10:41
라인
Kolon gets FDA nod for testing gene therapy for neuropathic pain
Kolon Life Science said Monday it obtained the U.S. Food and Drug Administr...
by Jeong Sae-im  |  2019-03-11 17:01
라인
LSK Global PS sets up subsidiary
LSK Global PS said Monday that it has established a subsidiary called LSK N...
by Lee Han-soo  |  2019-03-11 15:14
라인
LG Chem to develop sextuple influenza vaccine
LG Science Park in Gayang-dong, Seoul. LG Chem said Monday that it has re...
by Lee Han-soo  |  2019-03-11 14:31
라인
Jeil releases P3 clinical trial results for anti-hypertension treatment
Jeil Pharmaceutical said Monday that it has published the phase 3 clinical ...
by Lee Han-soo  |  2019-03-11 14:03
라인
Daewoong’s pulmonary fibrosis treatment wins government support
Daewoong Pharmaceutical said Friday that the Korea Drug Development Fund (K...
by Lee Han-soo  |  2019-03-08 16:57
라인
Gilead, Yuhan to co-promote Biktarvy
Yuhan Corp. said Friday that it has signed an agreement with Gilead Science...
by Lee Han-soo  |  2019-03-08 15:32
여백
여백
여백
Back to Top